Sort by
Refine Your Search
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Subject description This position will be linked to the project: Insect
-
the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description 1 researcher position
-
translational medicine and molecular biosciences. As part of this initiative, the SciLifeLab Drug Discovery and Development Platform (SciLifeLab DDD) was created to support academic drug discovery in Sweden
-
Development Agency (AUDA) - NEPAD African Science, Technology, and Innovation Indicators (ASTII) initiative and flagship graduate-level capacity building program Innovation, Transformation and Resilience
-
(R2) Country Sweden Application Deadline 13 Oct 2025 - 21:59 (UTC) Type of Contract Not Applicable Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Our research group studies the ecological and evolutionary drivers of floral
-
Recognised Researcher (R2) Country Sweden Application Deadline 15 Oct 2025 - 21:59 (UTC) Type of Contract Not Applicable Job Status Full-time Is the job funded through the EU Research Framework Programme? Not
-
19 Sep 2025 Job Information Organisation/Company Lunds universitet Department Lund University, Department of experimental medical science Research Field Medical sciences Computer science Mathematics
-
gradients in the tropical Andes, including sampling of plant-pollinator interactions, floral traits, and co-flowering communities Design and carry out pollination-efficiency and reproductive success
-
graduate-level capacity building program Innovation, Transformation and Resilience for Sustainable Development under the financial support of SIDA. The ASTII initiative is currently approaching the end